Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
18.30
Dollar change
-0.21
Percentage change
-1.13
%
IndexRUT P/E- EPS (ttm)-3.73 Insider Own38.57% Shs Outstand45.80M Perf Week2.52%
Market Cap782.87M Forward P/E- EPS next Y-3.91 Insider Trans-0.81% Shs Float26.28M Perf Month4.51%
Income-156.14M PEG- EPS next Q-0.96 Inst Own64.94% Short Float2.98% Perf Quarter123.44%
Sales0.00M P/S- EPS this Y-271.67% Inst Trans-1.52% Short Ratio2.11 Perf Half Y76.81%
Book/sh10.96 P/B1.67 EPS next Y4.22% ROA-28.08% Short Interest0.78M Perf Year61.80%
Cash/sh10.90 P/C1.68 EPS next 5Y- ROE-29.60% 52W Range7.64 - 19.68 Perf YTD79.59%
Dividend Est.- P/FCF- EPS past 5Y- ROI-33.13% 52W High-7.01% Beta0.34
Dividend TTM- Quick Ratio20.33 Sales past 5Y-25.00% Gross Margin- 52W Low139.53% ATR (14)0.98
Dividend Ex-Date- Current Ratio20.33 EPS Y/Y TTM-259.04% Oper. Margin0.00% RSI (14)65.14 Volatility5.92% 5.73%
Employees62 Debt/Eq0.01 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price25.50
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-68.61% Payout0.00% Rel Volume0.62 Prev Close18.51
Sales Surprise- EPS Surprise1.23% Sales Q/Q- EarningsNov 08 BMO Avg Volume371.44K Price18.30
SMA201.29% SMA5030.42% SMA20066.71% Trades Volume230,292 Change-1.13%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wedbush Outperform $30
Jun-15-23Initiated TD Cowen Outperform
Nov-21-22Initiated BTIG Research Buy $20
Apr-27-21Upgrade Morgan Stanley Equal-Weight → Overweight $40
Feb-02-21Initiated SVB Leerink Outperform $52
Feb-02-21Initiated Morgan Stanley Equal-Weight $38
Feb-02-21Initiated Evercore ISI Outperform $55
Feb-01-21Initiated H.C. Wainwright Buy $47
Mar-01-24 07:00AM
Feb-27-24 08:00AM
Feb-21-24 09:21AM
Feb-02-24 11:01PM
Jan-30-24 11:01PM
07:02PM Loading…
Jan-24-24 07:02PM
Dec-18-23 04:53PM
Dec-14-23 04:30PM
Nov-08-23 07:00AM
Nov-03-23 12:01PM
Oct-30-23 08:00AM
Sep-06-23 08:00AM
Aug-10-23 07:00AM
Aug-09-23 07:00AM
Aug-03-23 04:15PM
08:00AM Loading…
Jul-31-23 08:00AM
Jun-09-23 04:07PM
May-25-23 05:00PM
May-11-23 04:01PM
Apr-26-23 10:08AM
Apr-20-23 07:00AM
Mar-29-23 10:13AM
Mar-27-23 07:00AM
Mar-14-23 04:35PM
Mar-09-23 07:00AM
Feb-27-23 08:00AM
Feb-13-23 07:00PM
Feb-02-23 04:01PM
Feb-01-23 04:42PM
Jan-24-23 08:00AM
11:07AM Loading…
Jan-23-23 11:07AM
Jan-03-23 05:13PM
Dec-28-22 10:31PM
Dec-02-22 05:00PM
Nov-14-22 07:00AM
Nov-02-22 08:00AM
Nov-01-22 05:23PM
07:00AM
Oct-25-22 07:00AM
Oct-03-22 04:50PM
Sep-07-22 08:00AM
Sep-01-22 05:27PM
Aug-15-22 04:57PM
Aug-10-22 07:00AM
Aug-01-22 04:55PM
08:00AM
Jul-29-22 05:00AM
05:00AM
Jul-05-22 04:01PM
Jul-01-22 04:37PM
Jun-23-22 08:00AM
Jun-01-22 05:00PM
May-31-22 08:00AM
May-26-22 08:45AM
May-19-22 08:00AM
May-16-22 06:45AM
May-12-22 11:18AM
02:00AM
May-08-22 09:23AM
May-02-22 05:00PM
Apr-27-22 10:00AM
Apr-05-22 08:00AM
Apr-04-22 04:34PM
Mar-29-22 07:54AM
Mar-28-22 04:01PM
Mar-17-22 07:08AM
07:00AM
Mar-09-22 08:00AM
Mar-08-22 05:30PM
Feb-28-22 08:00AM
Feb-12-22 06:50AM
Feb-07-22 06:30AM
Jan-10-22 06:30AM
Jan-05-22 09:00AM
Jan-04-22 07:34AM
07:00AM
Dec-16-21 01:04PM
06:30AM
Dec-13-21 07:00AM
Nov-22-21 12:37PM
Nov-14-21 07:04AM
Nov-09-21 06:45AM
Oct-29-21 11:47AM
Oct-18-21 07:00AM
Sep-08-21 04:01PM
Aug-16-21 06:44AM
Aug-10-21 06:30AM
Aug-05-21 04:05PM
Jul-19-21 07:56PM
Jun-29-21 08:00AM
Jun-07-21 10:57AM
09:26AM
08:30AM
Jun-04-21 11:53AM
09:00AM
May-21-21 08:00AM
May-19-21 05:00PM
May-14-21 06:30AM
Apr-08-21 01:38AM
Apr-07-21 10:08AM
Cullinan Oncology, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Savill CorrineChief Business OfficerFeb 01Option Exercise4.3040,000172,000205,990Feb 02 09:35 PM
Savill CorrineChief Business OfficerFeb 01Sale16.1840,000647,200165,990Feb 02 09:35 PM
Savill CorrineChief Business OfficerJan 29Option Exercise4.3040,000172,000205,990Jan 30 07:00 PM
Savill CorrineChief Business OfficerJan 29Sale14.0940,000563,600165,990Jan 30 07:00 PM
Savill CorrineChief Business OfficerJan 23Option Exercise4.3021,31691,659187,306Jan 24 05:00 PM
Savill CorrineChief Business OfficerJan 23Sale12.4621,316265,597165,990Jan 24 05:00 PM
Savill CorrineChief Business OfficerJan 22Option Exercise4.3014,55962,604184,674Jan 24 05:00 PM
Savill CorrineChief Business OfficerJan 22Sale12.1418,684226,911165,990Jan 24 05:00 PM
AHMED NADIMPresident and CEODec 26Sale9.244,27239,473111,550Dec 27 06:30 PM
Trigilio JeffreyChief Financial OfficerDec 21Sale8.501,92016,32083,919Dec 22 05:30 PM
Jones Jeffrey AlanChief Medical OfficerDec 21Sale8.501,86015,81056,191Dec 22 05:30 PM
SUMER JACQUELYN LChief Legal OfficerDec 21Sale8.501,40011,90044,133Dec 22 05:30 PM
Michaelson JenniferChief Scientific OfficerDec 21Sale8.501,1459,73287,582Dec 22 05:30 PM
Trigilio JeffreyChief Financial OfficerDec 18Sale8.223983,27285,839Dec 20 06:00 PM
Jones Jeffrey AlanChief Medical OfficerDec 18Sale8.223863,17358,051Dec 20 06:00 PM
SUMER JACQUELYN LChief Legal OfficerDec 18Sale8.222902,38445,533Dec 20 06:00 PM
Michaelson JenniferChief Scientific OfficerDec 18Sale8.222381,95688,727Dec 20 06:00 PM
Trigilio JeffreyChief Financial OfficerDec 12Sale7.811,92615,04286,237Dec 13 08:00 PM
Michaelson JenniferChief Scientific OfficerDec 12Sale7.811,0688,34188,965Dec 13 08:00 PM
AHMED NADIMPresident and CEOJun 28Sale11.407598,653115,822Jun 29 04:59 PM
Trigilio JeffreyChief Financial OfficerJun 20Sale12.943995,16385,823Jun 21 04:17 PM
Jones Jeffrey AlanChief Medical OfficerJun 20Sale12.943875,00858,437Jun 21 04:17 PM
SUMER JACQUELYN LChief Legal OfficerJun 20Sale12.942913,76645,823Jun 21 04:17 PM
Michaelson JenniferChief Development OfficerJun 20Sale12.942383,08090,033Jun 21 04:17 PM
Trigilio JeffreyChief Financial OfficerJun 12Sale13.113194,18286,222Jun 14 04:35 PM
Michaelson JenniferChief Development OfficerJun 12Sale13.111762,30790,271Jun 14 04:35 PM
Michaelson JenniferChief Development OfficerJun 07Option Exercise4.3010043090,547Jun 08 05:10 PM
Michaelson JenniferChief Development OfficerJun 07Sale12.401001,24090,447Jun 08 05:10 PM
Michaelson JenniferChief Development OfficerJun 06Option Exercise4.3011,90051,170102,347Jun 08 05:10 PM
Michaelson JenniferChief Development OfficerJun 06Sale12.3111,900146,48990,447Jun 08 05:10 PM
AHMED NADIMPresident and CEOMay 23Sale9.157076,469116,581May 24 04:36 PM
Trigilio JeffreyChief Financial OfficerMay 18Sale8.763993,49586,541May 19 04:44 PM
Jones Jeffrey AlanChief Medical OfficerMay 18Sale8.763943,45158,824May 19 04:46 PM
SUMER JACQUELYN LChief Legal OfficerMay 18Sale8.762912,54946,114May 19 04:45 PM
Michaelson JenniferChief Development OfficerMay 18Sale8.762392,09490,447May 19 04:51 PM
Trigilio JeffreyChief Financial OfficerMay 12Sale8.783473,04786,940May 16 05:28 PM
Michaelson JenniferChief Development OfficerMay 12Sale8.781931,69590,686May 16 05:36 PM
AHMED NADIMPresident and CEOApr 25Sale10.597167,582117,288Apr 26 04:23 PM
Trigilio JeffreyChief Financial OfficerApr 18Sale10.713984,26387,287Apr 20 04:34 PM
Jones Jeffrey AlanChief Medical OfficerApr 18Sale10.713924,19859,218Apr 20 04:38 PM
SUMER JACQUELYN LChief Legal OfficerApr 18Sale10.712903,10646,405Apr 20 04:30 PM
Michaelson JenniferChief Development OfficerApr 18Sale10.712382,54990,879Apr 20 04:32 PM
Trigilio JeffreyChief Financial OfficerApr 12Sale10.223183,25087,685Apr 14 06:35 PM
Michaelson JenniferChief Development OfficerApr 12Sale10.221761,79991,117Apr 14 06:23 PM
AHMED NADIMPresident and CEOMar 23Sale10.517067,420118,004Mar 27 04:05 PM
Trigilio JeffreyChief Financial OfficerMar 20Sale11.323994,51788,003Mar 27 04:05 PM
Jones Jeffrey AlanChief Medical OfficerMar 20Sale11.323904,41559,610Mar 27 04:05 PM
SUMER JACQUELYN LChief Legal OfficerMar 20Sale11.323053,45346,695Mar 27 04:05 PM
Michaelson JenniferChief Development OfficerMar 20Sale11.322382,69491,293Mar 27 04:05 PM